Senna and Oracort drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Senna (senna) and Oracort (triamcinolone acetonide). Common drug interactions include pneumonia among females.

The phase IV clinical study analyzes what interactions people have when they take Senna and Oracort. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Senna?

Senna has active ingredients of senna. It is often used in constipation. eHealthMe is studying from 37,302 Senna users. Check the latest studies of Senna.

What is Oracort?

Oracort has active ingredients of triamcinolone acetonide. eHealthMe is studying from 175 Oracort users. Check the latest studies of Oracort.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

17 people who take Senna and Oracort together, and have interactions are studied.

Senna and Oracort drug interactions.

What are the common drug interactions of Senna and Oracort, by gender? *:

female:

  1. Pneumonia
  2. Pulmonary embolism (blockage of the main artery of the lung)
  3. Radiation pneumonitis (inflammation of lung due to radiation)
  4. Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
  5. Arthralgia (joint pain)
  6. Ocular hyperaemia (an abnormally large amount of blood in eye)
  7. Pain in extremity
  8. Pain of skin
  9. Somnolence (a state of near-sleep, a strong desire for sleep)
  10. Rash erythematous (redness of the skin)

male:

n/a

What are the common drug interactions of Senna and Oracort, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Pneumonia
  2. Pulmonary embolism (blockage of the main artery of the lung)
  3. Radiation pneumonitis (inflammation of lung due to radiation)
  4. Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
  5. Arthralgia (joint pain)
  6. Ocular hyperaemia (an abnormally large amount of blood in eye)
  7. Pain in extremity
  8. Pain of skin
  9. Somnolence (a state of near-sleep, a strong desire for sleep)
  10. Rash erythematous (redness of the skin)

What are the existing conditions these people have? *

  1. Pneumonia: 17 people, 100.00%
  2. Non-Small Cell Lung Cancer Stage 0: 16 people, 94.12%
  3. Lung Cancer - Non-Small Cell (lung cancer): 4 people, 23.53%

* Approximation only. Some reports may have incomplete information.

Do you take Senna and Oracort?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Senna and Oracort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Senna:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Oracort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Senna and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Oracort and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on senna and triamcinolone acetonide (the active ingredients of Senna and Oracort, respectively), and Senna and Oracort (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: